| 000 | 02497 a2200637 4500 | ||
|---|---|---|---|
| 005 | 20250514181337.0 | ||
| 264 | 0 | _c20040823 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a1524-4571 | ||
| 024 | 7 |
_a10.1161/01.RES.0000123826.70125.4D _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWen, Jin Fu | |
| 245 | 0 | 0 |
_aHigh and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria. _h[electronic resource] |
| 260 |
_bCirculation research _cApr 2004 |
||
| 300 |
_a936-43 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3',5'-Cyclic-AMP Phosphodiesterases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtrial Natriuretic Factor _xmetabolism |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 | _aCardiac Pacing, Artificial |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic GMP _xphysiology |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 2 |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 3 |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGuanylate Cyclase _xphysiology |
| 650 | 0 | 4 |
_aHeart Atria _xenzymology |
| 650 | 0 | 4 |
_aMilrinone _xpharmacology |
| 650 | 0 | 4 |
_aMolsidomine _xanalogs & derivatives |
| 650 | 0 | 4 | _aMyocardial Contraction |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aNatriuretic Peptide, C-Type _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPhosphoric Diester Hydrolases _xphysiology |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSecond Messenger Systems _xphysiology |
| 650 | 0 | 4 | _aSoluble Guanylyl Cyclase |
| 650 | 0 | 4 |
_aStroke Volume _xdrug effects |
| 700 | 1 | _aCui, Xun | |
| 700 | 1 | _aJin, Jing Yu | |
| 700 | 1 | _aKim, Soo Mi | |
| 700 | 1 | _aKim, Sung Zoo | |
| 700 | 1 | _aKim, Suhn Hee | |
| 700 | 1 | _aLee, Ho Sub | |
| 700 | 1 | _aCho, Kyung Woo | |
| 773 | 0 |
_tCirculation research _gvol. 94 _gno. 7 _gp. 936-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.RES.0000123826.70125.4D _zAvailable from publisher's website |
| 999 |
_c14709266 _d14709266 |
||